BWAM
REGN icon

Boyd Watterson Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Boyd Watterson Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$672K Sell
1,078
-9
-0.8% -$6.13K 0.18% 90
2026
Q1 		$840K Buy
1,087
+15
+1% +$11.5K 0.26% 72
2025
Q4 		$827K Buy
1,072
+20
+2% +$13.6K 0.24% 72
2025
Q3 		$592K Buy
1,052
+85
+9% +$48.1K 0.18% 91
2025
Q2 		$508K Buy
967
+77
+9% +$43K 0.16% 93
2025
Q1 		$564K Sell
890
-15
-2% -$10.3K 0.18% 91
2024
Q4 		$645K Sell
905
-286
-24% -$240K 0.18% 81
2024
Q3 		$1.25M Sell
1,191
-4
-0.3% -$4.45K 0.34% 62
2024
Q2 		$1.26M Hold
1,195
– – 0.36% 57
2024
Q1 		$1.15M Buy
1,195
+276
+30% +$262K 0.41% 54
2023
Q4 		$807K Sell
919
-17
-2% -$14K 0.32% 63
2023
Q3 		$770K Sell
936
-11
-1% -$8.64K 0.34% 62
2023
Q2 		$680K Hold
947
– – 0.27% 75
2023
Q1 		$778K Sell
947
-13
-1% -$9.8K 0.32% 73
2022
Q4 		$693K Buy
960
+9
+0.9% +$6.64K 0.29% 81
2022
Q3 		$655K Sell
951
-15
-2% -$9.44K 0.3% 79
2022
Q2 		$571K Sell
966
-6
-0.6% -$3.9K 0.24% 87
2022
Q1 		$679K Buy
972
+20
+2% +$12.7K 0.25% 93
2021
Q4 		$601K Hold
952
– – 0.2% 98
2021
Q3 		$576K Buy
952
+143
+18% +$88.8K 0.21% 100
2021
Q2 		$452K Sell
809
-1,443
-64% -$731K 0.18% 111
2021
Q1 		$1.07M Buy
2,252
+488
+28% +$238K 0.47% 68
2020
Q4 		$852K Buy
+1,764
New +$952K 0.41% 74

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Boyd Watterson Asset Management's REGN Position: Q2 2026 in Review

Boyd Watterson Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 0.83% in Q2 2026, selling an estimated $6.13K and leaving 1,078 shares worth $672K. The position accounts for 0.18% of the portfolio, ranked #90.

Boyd Watterson Asset Management first reported a position in REGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.26M in Q2 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Boyd Watterson Asset Management held 1,078 shares of Regeneron Pharmaceuticals worth $672K as of Q2 2026.
  • Boyd Watterson Asset Management sold 9 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $6.13K.
  • Regeneron Pharmaceuticals made up 0.18% of Boyd Watterson Asset Management's portfolio in Q2 2026, its #90 holding.
  • Boyd Watterson Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Boyd Watterson Asset Management's Regeneron Pharmaceuticals position peaked at $1.26M in Q2 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Boyd Watterson Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.